1 “... with the use of corticosteroids and eye drops based on the VEKTIS trial. In the manufacturer's base case...”

2 “...). It is available as a sterile topical ophthalmic solution containing 0.24 mg/mL LBN supplied in an eye-drop...”

3 “... with the use of corticosteroids and eye drops based on the VEKTIS trial. In the manufacturer's base case...”

4 “...). It is available as a sterile topical ophthalmic solution containing 0.24 mg/mL LBN supplied in an eye-drop...”

5 “... antiglaucoma medications. Patients with OSD may experience dry eye or sensations of burning, stinging, itching...”

6 “... antiglaucoma medications. Patients with OSD may experience dry eye or sensations of burning, stinging, itching...”

7 “... with cystinosis. The recommended dose for CH 0.55% is one drop of solution in each eye, four times per day during...”

8 “... effects of voretigene neparvovec administered as a single dose of 1.5 × 1011 vector genomes in each eye...”

9 “... segment of the eye, and for the treatment of adult patients with diabetic macular edema (DME) who...”

10 “... segment of the eye, and for the treatment of adult patients with diabetic macular edema (DME) who...”

11 “... brain or eye injury. This report will also review the evidence around the optimal dose of ketamine...”

12 “... for subretinal injection and the Health Canada-approved dose is 1.5 x 1011 vector genomes (vg) for each eye...”

13 “... solution with a recommended dose of one drop in the affected eye(s) per day. The manufacturer is requesting...”

14 “... is one drop in the affected eye(s) once daily. The manufacturer-submitted price was $20.54 per pack of 30...”

15 “... is one drop in the affected eye(s) once daily. The manufacturer-submitted price was $20.54 per pack of 30...”

16 “... solution with a recommended dose of one drop in the affected eye(s) per day. The manufacturer is requesting...”

17 “... to avoid corrective eye wear, patient satisfaction and quality of life. Cost-effectiveness of laser...”

18 “... injection to be administered per eye -- re-administered when there is presence of macular edema. The price...”

19 “... documented diagnosis of open-angle glaucoma or ocular hypertensionin one or both eyes. Pricing condition...”

20 “... documented diagnosis of open-angle glaucoma or ocular hypertensionin one or both eyes. Pricing condition...”